Vifor Pharma Articles
Vifor Fresenius PA21 filed for approval with US FDA, accepted by EMA
11 February 2013
Observational study suggests a role for Vifor's Ferinject for anemic and iron deficient patients with cancer
31 January 2013
Teijin debuts Ipsen's Somatuline in Japan; Galenica deal for Maltofer and Uro-Vaxom in China
18 January 2013
Showing 1-8 of 8 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
